Assuntos
Débito Cardíaco/fisiologia , Impedância Elétrica , Monitorização Intraoperatória/métodos , Volume Sistólico/fisiologia , Termodiluição/métodos , Adulto , Fatores Etários , Catéteres/efeitos adversos , Catéteres/economia , Criança , Ecocardiografia/economia , Ecocardiografia/métodos , Humanos , Monitorização Intraoperatória/efeitos adversos , Monitorização Intraoperatória/economia , Monitorização Intraoperatória/instrumentação , Artéria Pulmonar/fisiologia , Procedimentos Cirúrgicos Operatórios/efeitos adversos , Termodiluição/efeitos adversos , Termodiluição/economia , Termodiluição/instrumentaçãoRESUMO
BACKGROUND: The use of goal directed fluid protocols in intermediate risk patients undergoing hip or knee replacement was studied in few trials using invasive monitoring. For this reason we have implemented two different fluid management protocols, both based on a novel totally non-invasive arterial pressure monitoring device and compared them to the standard (no-protocol) treatment applied before the transition in our academic institution. METHODS: Three treatment groups were compared in this prospective study: the observational (CONTROL, N = 40) group before adoption of fluid protocols and two randomized groups after the transition to protocol fluid management with the use of the continuous non-invasive blood pressure monitoring (CNAP®) device. In the PRESSURE group (N = 40) standard variables were used for restrictive fluid therapy. Goal directed fluid therapy using pulse pressure variation was used in the GDFT arm (N = 40). The influence on the rate of postoperative complications, on the hospital length of stay and other parameters was assessed. RESULTS: Both protocols were associated with decreased fluid administration and maintained hemodynamic stability. Reduced rate of postoperative infection and organ complications (22 (55 %) vs. 33 (83 %) patients; p = 0.016; relative risk 0.67 (0.49-0.91)) was observed in the GDFT group compared to CONTROL. Lower number of patients receiving transfusion (4 (10 %) in GDFT vs. 17 (43 %) in CONTROL; p = 0.005) might contribute to this observation. No significant differences were observed in other end-points. CONCLUSION: In our study, the use of the fluid protocol based on pulse pressure variation assessed using continuous non-invasive arterial pressure measurement seems to be associated with a reduction in postoperative complications and transfusion needs as compared to standard no-protocol treatment. TRIAL REGISTRATION: ACTRN12612001014842.
Assuntos
Pressão Arterial/fisiologia , Artroplastia de Quadril/métodos , Artroplastia do Joelho/métodos , Hidratação/métodos , Monitorização Intraoperatória/métodos , Complicações Pós-Operatórias/prevenção & controle , Adulto , Idoso , Idoso de 80 Anos ou mais , Artroplastia de Quadril/efeitos adversos , Artroplastia do Joelho/efeitos adversos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Monitorização Intraoperatória/efeitos adversos , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/etiologia , Estudos ProspectivosAssuntos
Serviço Hospitalar de Anestesia/legislação & jurisprudência , Anestesiologia/legislação & jurisprudência , Atitude do Pessoal de Saúde , Política de Saúde/legislação & jurisprudência , Joint Commission on Accreditation of Healthcare Organizations/legislação & jurisprudência , Segurança do Paciente/legislação & jurisprudência , Centros de Traumatologia/legislação & jurisprudência , Ferimentos e Lesões/cirurgia , Anestesia/efeitos adversos , Anestesia/métodos , Anestesiologia/métodos , Atenção , Biomarcadores/sangue , Glicemia/metabolismo , Competência Clínica/legislação & jurisprudência , Medicina Baseada em Evidências/legislação & jurisprudência , Fidelidade a Diretrizes/legislação & jurisprudência , Humanos , Monitorização Intraoperatória/efeitos adversos , Monitorização Intraoperatória/métodos , Formulação de Políticas , Guias de Prática Clínica como Assunto , Medição de Risco , Fatores de Risco , Estados Unidos , Fluxo de Trabalho , Ferimentos e Lesões/diagnóstico , Ferimentos e Lesões/fisiopatologiaRESUMO
BACKGROUND: AMRA (adverse metabolic or muscular reaction to anesthesia) reports submitted to The North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States from 1987 to 2006 revealed a 2.7% cardiac arrest and a 1.4% death rate for 291 malignant hyperthermia (MH) events. We analyzed 6 years of recent data to update MH cardiac arrest and death rates, summarized characteristics associated with cardiac arrest and death, and documented differences between early and recent cohorts of patients in the MH Registry. We also tested whether the available data supported the hypothesis that risk of dying from an episode of MH is increased in patients with inadequate temperature monitoring. METHODS: We included U.S. or Canadian reports of adverse events after administration of at least 1 anesthetic drug, received between January 1, 2007, and December 31, 2012, with an MH clinical grading scale rank of "very likely MH" or "almost certain MH." We excluded reports that, after review, were judged to be due to pathologic conditions other than MH. We analyzed patient demographics, family and patient anesthetic history, anesthetic management including temperature monitoring, initial dantrolene dose, use of cardiopulmonary resuscitation, MH complications, survival, and reported molecular genetic DNA analysis of RYR1 and CACNA1S. A one-sided Cochran-Armitage test for proportions evaluated associations between mode of monitoring and mortality. We used Miettinen and Nurminen's method for assessing the relative risk of dying according to monitoring method. We used the P value of the slope to evaluate the relationship between duration of anesthetic exposure before dantrolene administration and peak temperature. We calculated the relative risk of death in this cohort compared with our previous cohort by using the Miettinen and Nurminen method adjusted for 4 comparisons. RESULTS: Of 189 AMRA reports, 84 met our inclusion criteria. These included 7 (8.3%) cardiac arrests, no successful resuscitations, and 8 (9.5%) deaths. Of the 8 patients who died, 7 underwent elective surgeries considered low to intermediate risk. The average age of patients who died was 31.4 ± 16.9 years. Five were healthy preoperatively. Three of the 8 patients had unrevealed MH family history. Four of 8 anesthetics were performed in freestanding facilities. In those who died, 3 MH-causative RYR1 mutations and 3 RYR1 variants likely to have been pathogenic were found in the 6 patients in whom RYR1 was examined. Compared to core temperature monitoring, the relative risk of dying with no temperature monitoring was 13.8 (lower limit 2.1). Compared to core temperature monitoring, the relative risk of dying with skin temperature monitoring was 9.7 (1.5). Temperature monitoring mode best distinguished patients who lived from those who died. End-tidal CO2 was the worst physiologic measure to distinguish patients who lived from those who died. Longer anesthetic exposures before dantrolene were associated with higher peak temperatures (P = 0.00056). Compared with the early cohort, the recent cohort had a higher percentage of MH deaths (4/291 vs 8/84; relative risk = 6.9; 95% confidence interval, 1.7-28; P = 0.0043 after adjustment for 4 comparisons). CONCLUSIONS: Despite a thorough understanding of the management of MH and the availability of a specific antidote, the risk of dying from an MH episode remains unacceptably high. To increase the chance of successful MH treatment, the American Society of Anesthesiologists and Malignant Hyperthermia Association of the U.S. monitoring standards should be altered to require core temperature monitoring for all general anesthetics lasting 30 minutes or longer.
Assuntos
Anestesia Geral/mortalidade , Regulação da Temperatura Corporal , Hipertermia Maligna/mortalidade , Monitorização Intraoperatória/mortalidade , Termometria/mortalidade , Adolescente , Adulto , Idoso , Anestesia Geral/efeitos adversos , Canais de Cálcio/genética , Canais de Cálcio Tipo L , Canadá/epidemiologia , Causas de Morte , Feminino , Predisposição Genética para Doença , Parada Cardíaca/mortalidade , Humanos , Masculino , Hipertermia Maligna/diagnóstico , Hipertermia Maligna/genética , Hipertermia Maligna/fisiopatologia , Pessoa de Meia-Idade , Monitorização Intraoperatória/efeitos adversos , Mutação , Valor Preditivo dos Testes , Sistema de Registros , Medição de Risco , Fatores de Risco , Canal de Liberação de Cálcio do Receptor de Rianodina/genética , Termometria/efeitos adversos , Fatores de Tempo , Estados Unidos/epidemiologia , Adulto JovemRESUMO
Intraoperative angiography in cerebrovascular neurosurgery can drive the repositioning or addition of aneurysm clips. Our institution has switched from a strategy of intraoperative digital subtraction angiography (DSA) universally, to a strategy of indocyanine green (ICG) videoangiography with DSA on an as-needed basis. We retrospectively evaluated whether the rates of perioperative stroke, unexpected postoperative aneurysm residual, or parent vessel stenosis differed in 100 patients from each era (2002, "DSA era"; 2007, "ICG era"). The clip repositioning rate for neck residual or parent vessel stenosis did not differ significantly between the two eras. There were no differences in the rate of perioperative stroke or rate of false-negative studies. The per-patient cost of intraoperative imaging within the DSA era was significantly higher than in the ICG era. The replacement of routine intraoperative DSA with ICG videoangiography and selective intraoperative DSA in cerebrovascular aneurysm surgery is safe and effective.
Assuntos
Angiografia Cerebral/métodos , Corantes , Verde de Indocianina , Aneurisma Intracraniano/patologia , Aneurisma Intracraniano/cirurgia , Monitorização Intraoperatória/métodos , Adulto , Idoso , Angiografia Digital/efeitos adversos , Angiografia Digital/economia , Angiografia Digital/métodos , Angiografia Cerebral/efeitos adversos , Angiografia Cerebral/economia , Constrição Patológica/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Monitorização Intraoperatória/efeitos adversos , Monitorização Intraoperatória/economia , Período Perioperatório , Estudos Retrospectivos , Acidente Vascular Cerebral/complicações , Tomografia Computadorizada por Raios X/efeitos adversos , Tomografia Computadorizada por Raios X/economia , Tomografia Computadorizada por Raios X/métodos , Resultado do Tratamento , Gravação em Vídeo/economia , Gravação em Vídeo/métodosRESUMO
The evaluation of LV global and segmental systolic function is a primary application for perioperative TEE. Although the practical techniques customarily used for these applications have limitations, they afford direct measures of function not otherwise available to the clinician in the operating room or intensive care setting.
Assuntos
Ecocardiografia Transesofagiana/métodos , Monitorização Intraoperatória/métodos , Função Ventricular Esquerda/fisiologia , Efeito Doppler , Ecocardiografia Transesofagiana/efeitos adversos , Humanos , Monitorização Intraoperatória/efeitos adversos , Sístole/fisiologiaRESUMO
BACKGROUND: The rate of intraoperative cholangiography fell after the advent of laparoscopic cholecystectomy due to the perceived difficulty of cystic duct cannulation. It is suggested that cholecystocholangiography (CCC) is a valid and easier alternative. The present study compares cystic duct cholangiography (CDC) to CCC with evaluation of procedural time, success rate, image quality, cost and radiation exposure. METHODS: Patients undergoing laparoscopic cholecystectomy were randomized to CCC (n = 40) or CDC (n = 36). Details of operative times, radiation exposure, and use of disposable equipment were recorded prospectively. Cholangiograms were performed using image intensification and were scored from 0 to 6 according to adequacy of images. Data were analysed on an intention-to-treat basis with the chi-squared test, t-test or Fisher's exact test. RESULTS: The success rate for CDC was 100% and for CCC it was 72% (P = 0.0005). Patients with a failed CCC went on to have CDC for a success rate in the CCC arm of 92.5%. Comparing CDC to CCC, there was no significant difference in cost ($30.16 vs $33.36: P = 0.11), operative time (1 h 13 min vs 1 h 3 min; P = 0.19) or cholangiogram time (8 vs 9 min: P = 0.39). There was a significant difference in screening time (0:41 vs 1:33 min; P < 0.0001), adequate image quality (100 vs 72.5%, P = 0.0005) and procedure-related complications (0 vs 5; P = 0.03). CONCLUSIONS: A significant number of CCC fail. Successful CCC provides inferior image quality and greater radiation exposure. It provides no benefit in time or cost and cannot be recommended for operative cholangiography.
Assuntos
Colangiografia/métodos , Colecistectomia Laparoscópica , Colecistografia/métodos , Monitorização Intraoperatória/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Distribuição de Qui-Quadrado , Colangiografia/efeitos adversos , Colangiografia/economia , Colangiografia/instrumentação , Colecistografia/efeitos adversos , Colecistografia/economia , Colecistografia/instrumentação , Feminino , Custos Hospitalares/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Monitorização Intraoperatória/efeitos adversos , Monitorização Intraoperatória/economia , Estudos Prospectivos , Monitoramento de Radiação , Reprodutibilidade dos Testes , Fatores de TempoRESUMO
OBJECT: Recurrent laryngeal nerve (RLN) injury occurs after anterior cervical spine procedures. In this study the authors used intraoperative electromyographic (EMG) monitoring of the posterior pharynx as a surrogate for RLN function and monitored endotracheal tube (ET) cuff pressure to determine if there was an association between these variables and clinical outcome. METHODS: Sixty patients in whom anterior cervical spine procedures were to be performed comprised the study population. After intubation, the ET cuff was adjusted to a just-seal volume and attached to a pressure monitor. A laryngeal surface electrode was placed in the posterior pharynx, and spontaneous EMG activity was monitored throughout the procedure. Cuff pressures and EMG activity were recorded during neck retraction and when EMG activity increased 20% above baseline. Patients were divided into two groups: those with sore throat/dysphonia and those without symptoms. Cuff pressures and EMG values were compared between groups, and the differences were correlated with clinical outcome. CONCLUSIONS: Hoarseness immediately after surgery was reported in 38% of patients whereas 15% exhibited severe symptoms. In symptomatic patients the period of intubation had been longer, and the ET cuff pressures had been elevated. In most patients EMG activity increased during insertion of the retractor and decreased after its removal. In these patients a greater number of episodes of elevated EMG activity during surgery were also noted. Two patients experienced prolonged hoarseness, and one required teflon injections of the vocal fold. This patient's EMG activity increased (15-18 times baseline) during surgery. In the few patients who were symptomatic with increased EMG activity, neither the timing nor direction of change could be associated with symptoms. Intubation time and elevated ET cuff pressure were the most important contributors to dysphonia and sore throat after anterior cervical spine surgery.